COST-EFFECTIVENESS OF PLERIXAFOR PLUS GCSF FOR MOBILIZATION OF PERIPHERAL BLOOD STEM CELLS IN PATIENTS WITH MYELOMA AND LYMPHOMA IN SPAIN

被引：0
|
作者：
Duarte, R. F. [1 ]
Perez-Simon, J. A. [2 ]
Martin, G. [3 ]
de la Rubia, J. [4 ]
Marin, P. [5 ]
Alvarez, M. A. [6 ]
Espinos, B. [7 ]
Roset, M. [7 ]
机构：
[1] Hosp Duran & Reynals, Inst Catala Oncol, Lhospitalet De Llobregat, Spain
[2] Hosp Univ Virgen del Rocio, Seville, Spain
[3] Banc Sang & Teixits, Barcelona, Spain
[4] Hosp Univ La Fe Valencia, Valencia, Spain
[5] Hosp Clin Barcelona, Barcelona, Spain
[6] Hosp Reina Sofia, Cordoba, Spain
[7] IMS Hlth, Barcelona, Spain
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.2118
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A423 / A423
页数：1
相关论文
共 50 条
  • [31] Mobilization of peripheral blood stem cells for autologous transplant in non-Hodgkin's lymphoma and multiple myeloma patients by plerixafor and G-CSF and detection of tumor cell mobilization by PCR in multiple myeloma patients
    S Fruehauf
    G Ehninger
    K Hübel
    J Topaly
    H Goldschmidt
    A D Ho
    S Müller
    M Moos
    K Badel
    G Calandra
    Bone Marrow Transplantation, 2010, 45 : 269 - 275
  • [32] Mobilization of peripheral blood stem cells for autologous transplant in non-Hodgkin's lymphoma and multiple myeloma patients by plerixafor and G-CSF and detection of tumor cell mobilization by PCR in multiple myeloma patients
    Fruehauf, S.
    Ehninger, G.
    Huebel, K.
    Topaly, J.
    Goldschmidt, H.
    Ho, A. D.
    Mueller, S.
    Moos, M.
    Badel, K.
    Calandra, G.
    BONE MARROW TRANSPLANTATION, 2010, 45 (02) : 269 - 275
  • [33] Chemotherapy-based versus chemotherapy-free stem cell mobilization (± plerixafor) in multiple myeloma patients: an Italian cost-effectiveness analysis
    Lazzaro, Carlo
    Castagna, Luca
    Lanza, Francesco
    Laszlo, Daniele
    Milone, Giuseppe
    Pierelli, Luca
    Saccardi, Riccardo
    BONE MARROW TRANSPLANTATION, 2021, 56 (08) : 1876 - 1887
  • [34] Chemotherapy-based versus chemotherapy-free stem cell mobilization (± plerixafor) in multiple myeloma patients: an Italian cost-effectiveness analysis
    Carlo Lazzaro
    Luca Castagna
    Francesco Lanza
    Daniele Laszlo
    Giuseppe Milone
    Luca Pierelli
    Riccardo Saccardi
    Bone Marrow Transplantation, 2021, 56 : 1876 - 1887
  • [35] The effect of preemptive use of plerixafor on stem cell mobilization in patients with lymphoma and multiple myeloma
    Uysal, Ayse
    Erkurt, Mehmet Ali
    Kuru, Irfan
    Kaya, Emin
    Berber, Ilhami
    Sarici, Ahmet
    Bicim, Soykan
    Kaya, Ahmet
    Hidayet, Emine
    MARMARA MEDICAL JOURNAL, 2023, 36 (01): : 65 - 71
  • [36] PLERIXAFOR USE FOR PERIPHERAL BLOOD STEM CELLS MOBILIZATION IN PAEDIATRIC MALIGNANT DISEASES
    Bernard, E.
    Normand, C.
    Bleyzac, N.
    Bergeron, C.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S489 - S489
  • [37] PRELIMINARY EXPERIENCE WITH PLERIXAFOR FOR PERIPHERAL BLOOD STEM CELL MOBILIZATION IN PEDIATRIC PATIENTS
    Hawks, R. G.
    Semidei-Pomales, M.
    Abendroth, H. E.
    Garvin, J. H.
    Cairo, M. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S197 - S197
  • [38] Results and Cost Effectiveness of "on-Demand" Plerixafor Added to Chemotherapy and Granulocyte Colony-Stimulating Factor for Peripheral Blood Stem Cell Mobilization in Multiple Myeloma
    Milone, Giuseppe
    Martino, Massimo
    Di Marco, Annalia
    Leotta, Salvatore
    Spadaro, Andrea
    Morelli, Mara
    Avola, Giuseppe
    Camuglia, Maria Grazia
    Cupri, Alessandra
    Zammit, Valentina
    Scalzulli, Potito Rosario
    Valeria, Calafiore
    Olivieri, Attilio
    Tripepi, Giovanni
    BLOOD, 2015, 126 (23)
  • [39] PLERIXAFOR PLUS G-CSF RESULTED IN SIMILAR COST BUT MORE PREDICTABLE DAYS OF APHERESIS COMPARED TO CHEMOTHERAPY PLUS GCSF FOR MOBILIZATION OF AUTOLOGOUS HEMATOPOIETIC STEM CELLS
    Shaughnessy, P.
    Islas-Ohlmayer, M.
    Murphy, J.
    Hougham, M.
    MacPherson, J.
    Winkler, K.
    Silva, M.
    Steinberg, M.
    Matous, J.
    Selvey, S.
    Maris, M.
    McSweeney, P. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S203 - S203
  • [40] Low-Dose Plerixafor is Effective and Less Costly for Peripheral Blood Stem Cell Mobilization in Patients with Lymphoma and Multiple Myeloma Undergoing Autologous Transplantation
    Gomez-Almaguer, David
    Colunga-Pedraza, Perla R.
    Marisol Alvarado-Navarro, Dalila
    Gomez-De Leon, Andres
    Sotomayor-Duque, Guillermo
    Salazar-Riojas, Rosario
    Graciela Cantu-Rodriguez, Olga
    Mendez-Ramirez, Nereida
    Homero Gutierrez-Aguirre, Cesar
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S139 - S139
12345